Nuclear structure in cancer cells (original) (raw)

• Beale, L. S. Examination of sputum from a case of cancer of the pharynx and the adjacent parts. Arch. Med. Lond. 2, 44 (1860). This paper established the use of cell structure as a central tool in the diagnosis of cancer.
  Google Scholar
• DeMay, R. M. The Art and Science of Cytopathology (American Society of Clinical Pathologists Press, Chicago, 1996). This standard clinical textbook and reference manual describes the changes in cell structure that occur in many different cancers and shows how these changes are used in the diagnosis of cancer by light microscopy.
  Google Scholar
• Fu, Y. S., Reagan, J. W. & Bennington, J. L. Pathology of the Uterine Cervix, Vagina, and Vulva (W. B. Saunders Company, Philadelphia, 1989).
  Google Scholar
• Nickerson, J. Experimental observations of a nuclear matrix. J. Cell Sci. 114, 463–474 (2001). This comprehensive review of the nuclear matrix describes the ultrastructure and composition of this structure. It also discusses the methods that are used to isolate the nuclear matrix and addresses controversies about nuclear-matrix isolation protocols.
  CAS PubMed Google Scholar
• Nickerson, J. A., Krockmalnic, G., Wan, K. M. & Penman, S. The nuclear matrix revealed by eluting chromatin from a cross-linked nucleus. Proc. Natl Acad. Sci. USA 94, 4446–4450 (1997).
  CAS PubMed PubMed Central Google Scholar
• Monneron, A. & Bernhard, W. Fine structural organization of the interphase nucleus in some mammalian cells. J. Ultrastruct. Res. 27, 266–288 (1969).
  CAS PubMed Google Scholar
• Fey, E. G., Krochmalnic, G. & Penman, S. The nonchromatin substructures of the nucleus: the ribonucleoprotein (RNP)-containing and RNP-depleted matrices analyzed by sequential fractionation and resinless section electron microscopy. J. Cell Biol. 102, 1654–1665 (1986).
  CAS PubMed Google Scholar
• Mattern, K. A., Humbel, B. M., Muijsers, A. O., de Jong, L. & van Driel, R. hnRNP proteins and B23 are the major proteins of the internal nuclear matrix of HeLa S3 cells. J. Cell. Biochem. 62, 275–289 (1996).
  CAS PubMed Google Scholar
• Mancini, M. A., He, D., Ouspenski, I. I. & Brinkley, B. R. Dynamic continuity of nuclear and mitotic matrix proteins in the cell cycle. J. Cell. Biochem. 62, 158–164 (1996).
  CAS PubMed Google Scholar
• Vogelstein, B., Pardoll, D. M. & Coffey, D. S. Supercoiled loops and eucaryotic DNA replicaton. Cell 22, 79–85 (1980).
  CAS PubMed Google Scholar
• Bode, J. et al. Biological significance of unwinding capability of nuclear matrix-associating DNAs. Science 255, 195–197 (1992).
  CAS PubMed Google Scholar
• Benham, C., Kohwi-Shigematsu, T. & Bode, J. Stress-induced duplex DNA destabilization in scaffold/matrix attachment regions. J. Mol. Biol. 274, 181–196 (1997).
  CAS PubMed Google Scholar
• Yanagisawa, J., Ando, J., Nakayama, J., Kohwi, Y. & Kohwi-Shigematsu, T. A matrix attachment region (MAR)-binding activity due to a p114 kilodalton protein is found only in human breast carcinomas and not in normal and benign breast disease tissues. Cancer Res. 56, 457–462 (1996).
  CAS PubMed Google Scholar
• Cai, S., Han, H. J. & Kohwi-Shigematsu, T. Tissue-specific nuclear architecture and gene expression regulated by SATB1. Nature Genet. 34, 42–51 (2003).
  CAS PubMed Google Scholar
• Alvarez, J. D. et al. The MAR-binding protein SATB1 orchestrates temporal and spatial expression of multiple genes during T-cell development. Genes Dev. 14, 521–35 (2000).
  CAS PubMed PubMed Central Google Scholar
• Woynarowski, J. M. AT islands- their nature and potential for anticancer strategies. Curr. Cancer Drug Targets 4, 219–234 (2004).
  CAS PubMed Google Scholar
• Pitot, H. C. et al. Phase I study of bizelesin (NSC 615291) in patients with advanced solid tumors. Clin. Cancer Res. 8, 712–717 (2002).
  CAS PubMed Google Scholar
• Schwartz, G. H. et al. A phase I study of bizelesin, a highly potent and selective DNA-interactive agent, in patients with advanced solid malignancies. Ann. Oncol. 14, 775–782 (2003).
  CAS PubMed Google Scholar
• Fey, E. G. & Penman, S. Nuclear matrix proteins reflect cell type of origin in cultured human cells. Proc. Natl Acad. Sci. USA 85, 121–125 (1988).
  CAS PubMed PubMed Central Google Scholar
• Dworetzky, S. I. et al. Progressive changes in the protein composition of the nuclear matrix during rat osteoblast differentiation. Proc. Natl Acad. Sci. USA 87, 4605–4609 (1990).
  CAS PubMed PubMed Central Google Scholar
• Leman, E. S. & Getzenberg, R. H. Nuclear matrix proteins as biomarkers in prostate cancer. J. Cell. Biochem. 86, 213–223 (2002).
  CAS PubMed Google Scholar
• Coffey, D. S. Nuclear matrix proteins as proteomic markers of preneoplastic and cancer lesions: commentary re: G. Brunagel et al. nuclear matrix protein alterations associated with colon cancer metastasis to the liver. Clin Cancer Res. 8, 3031–3033 (2002).
  PubMed Google Scholar
• Partin, A. W. et al. Preliminary immunohistochemical characterization of a monoclonal antibody (PRO:4-216) prepared from human prostate cancer nuclear matrix proteins. Urology 50, 800–808 (1997).
  CAS PubMed Google Scholar
• Nickerson, J. A. Nuclear dreams: the malignant alteration of nuclear architecture. J. Cell. Biochem. 70, 172–180 (1998).
  CAS PubMed Google Scholar
• Sukhai, M. A. et al. Myeloid leukemia with promyelocytic features in transgenic mice expressing hCG–NuMA–RARα. Oncogene 23, 665–678 (2004).
  CAS PubMed Google Scholar
• Van Le, T. S., Myers, J., Konety, B. R., Barder, T. & Getzenberg, R. H. Functional characterization of the bladder cancer marker, BLCA-4. Clin. Cancer Res. 10, 1384–1391 (2004).
  CAS PubMed Google Scholar
• Goldman, R. D., Gruenbaum, Y., Moir, R. D., Shumaker, D. K. & Spann, T. P. Nuclear lamins: building blocks of nuclear architecture. Genes. Dev. 16, 533–547 (2002).
  CAS PubMed Google Scholar
• Broers, J. L. et al. Nuclear A-type lamins are differentially expressed in human lung cancer subtypes. Am. J. Pathol. 143, 211–220 (1993).
  CAS PubMed PubMed Central Google Scholar
• Mounkes, L., Kozlov, S., Burke, B. & Stewart, C. L. The laminopathies: nuclear structure meets disease. Curr. Opin. Genet. Dev. 13, 223–230 (2003).
  CAS PubMed Google Scholar
• Ostlund, C. & Worman, H. J. Nuclear envelope proteins and neuromuscular diseases. Muscle Nerve 27, 393–406 (2003).
  CAS PubMed Google Scholar
• Zastrow, M. S., Vlcek, S. & Wilson, K. L. Proteins that bind A-type lamins: integrating isolated clues. J. Cell Sci. 117, 979–987 (2004).
  CAS PubMed Google Scholar
• Brown, K. E. et al. Association of transcriptionally silent genes with Ikaros complexes at centromeric heterochromatin. Cell 91, 845–854 (1997). This is a classic paper describing relationships between gene positioning and transcriptional regulation.
  CAS PubMed Google Scholar
• Skok, J. A. et al. Nonequivalent nuclear location of immunoglobulin alleles in B lymphocytes. Nature Immunol. 2, 825–826 (2001).
  Google Scholar
• Kosak, S. T. et al. Subnuclear compartmentalization of immunoglobulin loci during lymphocyte development. Science 296, 158–162 (2002).
  CAS PubMed Google Scholar
• Zink, D. et al. Transcription-dependent spatial arrangements of CFTR and adjacent genes in human cell nuclei. J. Cell Biol. (in the press).
• Morris, G. E. The role of the nuclear envelope in Emery–Dreifuss muscular dystrophy. Trends Mol. Med. 7, 572–577 (2001).
  CAS PubMed Google Scholar
• Lee, K. K. et al. Distinct functional domains in emerin bind lamin A and DNA-bridging protein BAF. J. Cell Sci. 114, 4567–4573 (2001).
  CAS PubMed Google Scholar
• Jhiang, S. M. The RET proto-oncogene in human cancers. Oncogene 19, 5590–5597 (2000).
  CAS PubMed Google Scholar
• Viglietto, G. et al. RET/PTC oncogene activation is an early event in thyroid carcinogenesis. Oncogene 11, 1207–1210 (1995).
  CAS PubMed Google Scholar
• Tallini, G. et al. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes. Clin. Cancer Res. 4, 287–294 (1998).
  CAS PubMed Google Scholar
• Jhiang, S. M. et al. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas. Endocrinology 137, 375–378 (1996).
  CAS PubMed Google Scholar
• Bond, J. A., Wyllie, F. S., Rowson, J., Radulescu, A. & Wynford-Thomas, D. In vitro reconstruction of tumour initiation in a human epithelium. Oncogene 9, 281–290 (1994).
  CAS PubMed Google Scholar
• Fischer, A. H., Taysavang, P. & Jhiang, S. M. Nuclear envelope irregularity is induced by RET/PTC during interphase. Am. J. Pathol. 163, 1091–1100 (2003).
  CAS PubMed PubMed Central Google Scholar
• Fischer, A. H., Bond, J. A., Taysavang, P., Battles, O. E. & Wynford-Thomas, D. Papillary thyroid carcinoma oncogene (RET/PTC) alters the nuclear envelope and chromatin structure. Am. J. Pathol. 153, 1443–1450 (1998). Reports that expression of RET/PTC , the oncogene expressed in papillary carcinoma of the thyroid, is sufficient to induce the changes in nuclear shape and chromatin distribution that are characteristic of these cancer cells.
  CAS PubMed PubMed Central Google Scholar
• Fischer, A. H. et al. in Cold Spring Harbor Symposium: Dynamic Organization of Nuclear Function (Cold Spring Harbor, New York, 2000).
  Google Scholar
• Kurokawa, K., Kawai, K., Hashimoto, M., Ito, Y. & Takahashi, M. Cell signalling and gene expression mediated by RET tyrosine kinase. J. Intern. Med. 253, 627–633 (2003).
  CAS PubMed Google Scholar
• Shi, N. et al. Structural basis for the specific recognition of RET by the Dok1 phosphotyrosine binding domain. J. Biol. Chem. 279, 4962–4969 (2004).
  CAS PubMed Google Scholar
• Consortium, I. H. G. S. Initial sequencing and analysis of the human genome. Nature 409, 860–921 (2001). The sequence of the human genome.
  Google Scholar
• Ferreira, J., Paolella, G., Ramos, C. & Lamond, A. I. Spatial organization of large-scale chromatin domains in the nucleus: a magnified view of single chromosome territories. J. Cell Biol. 139, 1597–1610 (1997).
  CAS PubMed PubMed Central Google Scholar
• Sadoni, N. et al. Nuclear organization of mammalian genomes: polar chromosome territories build up functionally distinct higher order compartments. J. Cell Biol. 146, 1211–1226 (1999). Provides comprehensive insights into the relationships between mitotic chromosome structure and the functional organization of mammalian genomes in the nucleus.
  CAS PubMed PubMed Central Google Scholar
• Boyle, S. et al. The spatial organization of human chromosomes within cell nuclei of normal and emerin-mutant cells. Hum. Mol. Genet. 10, 211–219 (2001).
  CAS PubMed Google Scholar
• Croft, J. A. et al. Differences in the localization and morphology of chromosomes in the human nucleus. J. Cell Biol. 145, 1119–1131 (1999). Established the use of chromosomes 18 and 19 as a model system for studying the radial distribution of chromosome territories and showed gene-density-dependent radial positioning.
  CAS PubMed PubMed Central Google Scholar
• Cremer, M. et al. Non-random radial higher-order chromatin arrangements in nuclei of diploid human cells. Chromosome Res. 9, 541–567 (2001).
  CAS PubMed Google Scholar
• Dimitrova, D. & Berezney, R. The spatio-temporal organization of DNA replication sites is identical in primary, immortalized and transformed mammalian cells. J. Cell Sci. 115, 4037–4051 (2002).
  CAS PubMed Google Scholar
• Cremer, M. et al. Inheritance of gene density-related higher order chromatin arrangements in normal and tumor cell nuclei. J. Cell Biol. 162, 809–820 (2003).
  CAS PubMed PubMed Central Google Scholar
• Nikiforova, M. N. et al. Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells. Science 290, 138–141 (2000).
  CAS PubMed Google Scholar
• Roix, J. J., McQueen, P. G., Munson, P. J., Parada, L. A. & Misteli, T. Spatial proximity of translocation-prone gene loci in human lymphomas. Nature Genet. 34, 287–291 (2003). Detailed statistical analysis of gene positioning in relation to the frequency of chromosomal translocations involving corresponding gene loci.
  CAS PubMed Google Scholar
• Parada, L. A., McQueen, P. G., Munson, P. J. & Misteli, T. Conservation of relative chromosome positioning in normal and cancer cells. Curr. Biol. 12, 1692–1697 (2002).
  CAS PubMed Google Scholar
• Kozubek, S. et al. The topological organization of chromosomes 9 and 22 in cell nuclei has a determinative role in the inducation of t(9,22) translocations and in the pathogenesis of t(9,22) leukemias. Chromosoma 108, 426–435 (1999).
  CAS PubMed Google Scholar
• The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 89, 3909–3918 (1997).
• Mühlmann, M. Molecular cytogenetics in metphase and interphase cells for cancer and genetic research, diagnosis and prognosis. Application in tissue sections and cell suspensions. Genet. Mol. Res. 1, 117–127 (2002).
  PubMed Google Scholar
• Frost, J. K. The Cell in Health and Disease: An Evaluation of Cellular Morphologic Expression of Biologic Behavior (Karger, New York, 1986).
  Google Scholar
• Lukasova, E. et al. Topography of genetic loci in the nuclei of cells of colorectal carcinoma and adjacent tissue of colonic epithelium. Chromosoma 112, 221–230 (2004).
  PubMed Google Scholar
• Fischer, A. H., Chaddee, D. N., Wright, J. A., Gansler, T. S. & Davie, J. R. Ras-associated nuclear structural change appears functionally significant and independent of the mitotic signaling pathway. J. Cell. Biochem. 70, 130–140 (1998).
  CAS PubMed Google Scholar
• Hake, S. B., Xiao, A. & Allis, C. D. Linking the epigenetic 'language' of covalent histone modifications to cancer. Br. J. Cancer 90, 761–769 (2004).
  CAS PubMed PubMed Central Google Scholar
• Robertson, K. D. DNA methylation, methyltransferases, and cancer. Oncogene 20, 3139–3155 (2001).
  CAS PubMed Google Scholar
• Roberts, C. W. & Orkin, S. H. The SWI/SNF complex- chromatin and cancer. Nature Rev. Cancer 4, 133–142 (2004).
  CAS Google Scholar
• Mathon, N. F. & Lloyd, A. C. Cell senescence and cancer. Nature Rev. Cancer 1 (2001).
• Campisi, J. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol. 11, S27–S31 (2001).
  CAS PubMed Google Scholar
• te Poele, R. H., Okorokov, A. L., Jardine, L., Cummings, J. & Joel, S. P. DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res. 62, 1876–1883 (2002).
  CAS PubMed Google Scholar
• Schmitt, C. A. et al. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 109, 335–346 (2002).
  CAS PubMed Google Scholar
• Narita, M. et al. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113, 703–716 (2003).
  CAS PubMed Google Scholar
• Nielsen, S. J. et al. Rb targets histone H3 methylation and HP1 to promoters. Nature 412, 561–565 (2001).
  CAS PubMed Google Scholar
• Henderson, A. S., Warburton, D. & Atwood, K. C. Location of ribosomal DNA in the human chromosome complement. Proc. Natl Acad. Sci. USA 69, 3394–3398 (1972).
  CAS PubMed PubMed Central Google Scholar
• Fischer, A. H., Bardarov, S. Jr. & Jiang, Z. Molecular aspects of diagnostic nucleolar and nuclear envelope changes in prostate cancer. J. Cell. Biochem. 91, 170–181 (2004).
  CAS PubMed Google Scholar
• Liebhaber, S. A., Wolf, S. & Schlessinger, D. Differences in rRNA metabolism of primary and SV40-transformed human fibroblasts. Cell 13, 121–127 (1978).
  CAS PubMed Google Scholar
• Derenzini, M. et al. Nucleolar size indicates the rapidity of cell proliferation in cancer tissues. J. Pathol. 191, 181–186 (2000).
  CAS PubMed Google Scholar
• Olson, M. O. Sensing cellular stress: another new function for the nucleolus? Sci. STKE 9 Mar 2004 (doi:10.1126/stke.2242004pe10).
• Pederson, T. The plurifunctional nucleolus. Nucleic Acids Res. 26, 3871–3876 (1998).
  CAS PubMed PubMed Central Google Scholar
• Huang, S. Perinucleolar structures. J. Struct. Biol. 129, 233–240 (2000).
  CAS PubMed Google Scholar
• Huang, S., Deerinck, T. J., Ellisman, M. H. & Spector, D. L. The dynamic organization of the perinucleolar compartment in the cell nucleus. J. Cell Biol. 137, 965–974 (1997). Describes the structure of the PNC and provides evidence that the PNC is much more prevalent in cancer cells.
  CAS PubMed PubMed Central Google Scholar
• Ghetti, A., Pinol-Roma, S., Michael, W. M., Morandi, C. & Dreyfuss, G. hnRNP I, the polypyrimidine tract-binding protein: distinct nuclear localization and association with hnRNAs. Nucleic Acids Res. 20, 3671–3678 (1992).
  CAS PubMed PubMed Central Google Scholar
• Wang, C., Politz, J. C., Pederson, T. & Huang, S. RNA polymerase III transcripts and the PTB protein are essential for the integrity of the perinucleolar compartment. Mol. Biol. Cell 14, 2425–2435 (2003).
  CAS PubMed PubMed Central Google Scholar
• Matera, A. G., Frey, M. R., Margelot, K. & Wolin, S. L. A perinucleolar compartment contains several RNA polymerase III transcripts as well as the polypyrimidine tract-binding protein, hnRNP I. J. Cell Biol. 129, 1181–1193 (1995).
  CAS PubMed Google Scholar
• Lee, B., Matera, A. G., Ward, D. C. & Craft, J. Association of RNase mitochondrial RNA processing enzyme with ribonuclease P in higher ordered structures in the nucleolus: a possible coordinate role in ribosome biogenesis. Proc. Natl Acad. Sci. USA 93, 11471–11476 (1996).
  CAS PubMed PubMed Central Google Scholar
• Zhong, S. et al. Role of SUMO-1 modified PML in nuclear body formation. Blood 95, 2748–2752 (2000).
  CAS PubMed Google Scholar
• Lallemand-Breitenbach, V. et al. Role of promyelocytic leukemia (PML) sumoylation in nuclear body formation, 11S roteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor α degradation. J. Exp. Med. 193, 1361–1371 (2001).
  CAS PubMed PubMed Central Google Scholar
• Zhong, S., Salomoni, P. & Pandolfi, P. P. The transcriptional role of PML and the nuclear body. Nature Cell Biol. 2, E85–E90 (2000).
  CAS PubMed Google Scholar
• Hodges, M., Tissot, C., Howe, K., Grimwade, D. & Freemnot, P. S. Structure, organization, and dynamics of promyelocytic leukemia protein nuclear bodies. Am. J. Med. Genet. 63, 297–304 (1998).
  CAS Google Scholar
• Pearson, M. et al. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 406, 207–210 (2000).
  CAS PubMed Google Scholar
• Fogal, V. et al. Regulation of p53 activity in nuclear bodies by a specific PML isoform. EMBO J. 19, 6185–6195 (2000).
  CAS PubMed PubMed Central Google Scholar
• Bernardi, R. & Pandolfi, P. P. Role of PML and the PML-nuclear body in the control of programmed cell death. Oncogene 22, 9048–9057 (2003).
  CAS PubMed Google Scholar
• Wang, Z. -G. et al. Pml is essential for multiple apoptotic pathways. Nature Genet. 20, 266–272 (1998).
  CAS PubMed Google Scholar
• Melnick, A. & Licht, J. D. Deconstructing a disease: RARα, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93, 3167–3215 (1999).
  CAS PubMed Google Scholar
• de Thé, H., Chomienne, C., Lanotte, M., Degos, L. & Dejean, A. The t(15;17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor α to a novel transcribed locus. Nature 347, 558–561 (1990).
  PubMed Google Scholar
• Borrow, J., Goddard, A. D., Sheer, D. & Solomon, E. Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science 249, 1577–1580 (1990).
  CAS PubMed Google Scholar
• Koken, M. H. M. et al. The t(15;17) translocation alters a nuclear body in a retinoic-acid reversible fashion. EMBO J. 13, 1073–1083 (1994).
  CAS PubMed PubMed Central Google Scholar
• Dyck, J. A. et al. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 76, 333–343 (1994).
  CAS PubMed Google Scholar
• Daniel, M. T. et al. PML protein expression in hematopoietic and acute promyelocytic leukemia cells. Blood 82, 1858–1867 (1993). First paper to show that PML bodies are lost in the leukaemic blasts of patients with APL and that they are restored after successful treatment with ATRA, an agent that re-differentiates these cells. These observations make the most convincing case for the clinical significance of the PML body in patients.
  CAS PubMed Google Scholar
• Weis, K. et al. Retinoic acid regulates aberrant nuclear localization of PML–RARα in acute promyelocytic leukemia cells. Cell 76, 345–356 (1994).
  CAS PubMed Google Scholar
• Huang, M. E. et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72, 567–572 (1988).
  CAS PubMed Google Scholar
• Wang, Z. Y. Ham–Wasserman Lecture: Treatment of acute leukemia by inducing differentiation and apoptosis. Hematology (Am. Soc. Hematol. Educ. Program) 1–13 (2003).
• Huang, M. E., Ye, Y. C. & Wang, Z. Y. Treatment of 4 APL patients with all-trans retinoic acid. Chin. J. Intern. Med. 26, 330–322 (1987).
  CAS Google Scholar
• Lengfelder, E., Gnad, U., Büchner, T. & Hehlmann, R. Treatment of relapsed acute promyelocytic leukemia. Onkologie 26, 373–379 (2003).
  CAS PubMed Google Scholar
• Zhu, J. et al. Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor α (RARα) and oncogenic RARα fusion proteins. Proc. Natl Acad. Sci. USA 96, 14807–14812 (1999).
  CAS PubMed PubMed Central Google Scholar
• Zhu, J. Lallemand-Breitenbach, V. & de Thé, H. Pathways of retinoic acid- or arsenic trioxide-induced PML/RARα catabolism, role of oncogene degradation in disease remission. Oncogene 20, 7257–7265 (2001).
  CAS PubMed Google Scholar
• Rego, E. M., He, L. -Z., Warrell, R. P. Jr., Wang, Z. -G. & Pandolfi, P. P. Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML–RARα and PLZF–RARα oncoproteins. Proc. Natl Acad. Sci. USA 97, 10173–10178 (2000).
  CAS PubMed PubMed Central Google Scholar
• Zhu, J. et al. Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia. Proc. Natl Acad. Sci. USA 94, 3978–3983 (1997).
  CAS PubMed PubMed Central Google Scholar
• Zhu, J., Chen, Z., Lallemand-Breitenbach, V. & de Thé, H. How acute promyelocytic leukaemia revived arsenic. Nature Rev. Cancer 2, 705–713 (2002). Excellent review about the use of arsenic compounds for medical treatment.
  CAS Google Scholar
• Terris, B. et al. PML nuclear bodies are general targets for inflammation and cell proliferation. Cancer Res. 55, 1590–1597 (1995).
  CAS PubMed Google Scholar
• Chan, J. Y., Chin, W., Liew, C. T., Chang, K. S. & Johnson, P. J. Altered expression of the growth and transformation suppressor PML gene in human hepatocellular carcinomas and in hepatitis tissues. Eur. J. Cancer 34, 1015–1022 (1998).
  CAS PubMed Google Scholar
• Gambacorta, M. et al. Heterogenous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues. Am. J. Pathol. 149, 2023–2035 (1996).
  CAS PubMed PubMed Central Google Scholar
• Koken, M. H. et al. The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene 10, 1315–1324 (1995).
  CAS PubMed Google Scholar
• Gurrieri, C. et al. Loss of the tumor suppressor PML in human cancers of multiple histologic origins. J. Natl Cancer Inst. 96, 269–279 (2004).
  CAS PubMed Google Scholar
• Zhang, P. et al. Lack of expression for the suppressor PML in human small cell lung carcinoma. Int. J. Cancer 85, 599–605 (2000).
  CAS PubMed Google Scholar
• Masood, A. K. et al. Quantitative alterations in nuclear structure predict prostate carcinoma distant metastasis and death in men with biochemical recurrence after radical prostatectomy. Am. Cancer Soc. 2583–2591 (2003).
• Millot, C. & Dufer, J. Clinical applications of image cytometry to human tumour analysis. Histol. Histopathol. 15, 1185–1200 (2000).
  CAS PubMed Google Scholar
• Pienta, K. J. & Coffey, D. S. Correlation of nuclear morphometry with progression of breast cancer. Cancer 68, 2012–2016 (1991).
  CAS PubMed Google Scholar
• Abulafia, O. & Sherer, D. M. Automated cervical cytology: meta-analyses of the performance of the PAPNET system. Obstet. Gynecol. Surv. 54, 253–264 (1999).
  CAS PubMed Google Scholar
• Mango, L. J. The FDA review process: obtaining premarket approval for the PAPNET Testing System. Acta Cytol. 40, 138–140 (1996).
  CAS PubMed Google Scholar
• Gozzetti, A. & Le Beau, M. M. Fluorescence in situ hybridization: uses and limitations. Semin. Hematol. 37, 320–333 (2000).
  CAS PubMed Google Scholar
• Remstein, E. D. et al. Diagnostic utility of fluorescent in situ hybridization in mantle-cell lymphoma. Br. J. Haematol. 110, 856–862 (2000).
  CAS PubMed Google Scholar
• Siebert, R. & Weber-Matthiesen, K. Fluorescence in situ hybridization as a diagnostic tool in malignant lymphomas. Histochem. Cell Biol. 108, 381–402 (1997).
  Google Scholar
• Martin-Subero, J. I., Gesk, S., Harder, L., Grote, W. & Siebert, R. Interphase cytogenetics of hematological neoplasms under the perspective of the novel WHO classification. Anticancer Res. 23, 1139–1148 (2003).
  PubMed Google Scholar
• Weber-Matthiesen, K., Winkemann, M., Muller-Hermeling, A., Schlegelberger, B. & Grote, W. Simultaneous fluorescence immunophenotyping and interphase cytogenetics: a contribution to the characterization of tumour cells. J. Histochem. Cytochem. 40, 171–175 (1992).
  CAS PubMed Google Scholar
• Martinez-Ramirez, A. et al. Simultaneous detection of the immunophenotypic markers and genetic aberrations on routinely processed paraffin sections of lymphoma samples by means of the FICTION technique. Leukemia 18, 348–353 (2004).
  CAS PubMed Google Scholar
• Martin-Subero, J. I. et al. Multicolor-FICTION: Expanding the possibilities of combined morphologic, immunophenotypic, and genetic single cell analyses. Am. J. Pathol. 161, 413–420 (2002).
  CAS PubMed PubMed Central Google Scholar
• Keesee, S. K., Briggman, J. V., Thill, G. & Wu, Y. J. Utilization of nuclear matrix proteins for cancer diagnosis. Crit. Rev. Eukaryot. Gene Expr. 6, 189–214 (1996).
  CAS PubMed Google Scholar
• Soloway, M. S. et al. Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment. J. Urol. 156, 363–367 (1996).
  CAS PubMed Google Scholar
• Huang, S., Rhee, E., Patel, H., Park, E. & Kaswick, J. Urinary NMP22 and renal cell carcinoma. Urology 55, 227–230 (2000).
  CAS PubMed Google Scholar
• Taimen, P., Viljamaa, M. & Kallajoki, M. Preferential expression of NuMA in the nuclei of proliferating cells. Exp. Cell Res. 256, 140–149 (2000).
  CAS PubMed Google Scholar
• Atsu, N. et al. False-positive results of the NMP22 test due to hematuria. J. Urol. 167, 555–558 (2002).
  PubMed Google Scholar
• Liebel, U. et al. A microscope-based screening platform for large-scale functional protein analysis in intact cells. FEBS Lett. 554, 394–398 (2003).
  CAS PubMed Google Scholar
• Kozubek, M. et al. High-resolution cytometry of FISH dots in interphase cell nuclei. Cytometry 36, 279–293 (1999).
  CAS PubMed Google Scholar
• Kozubek, M. et al. Combined confocal and wide-field high-resolution cytometry of fluorescent in situ hybridization-stained cells. Cytometry 45, 1–12 (2001).
  CAS PubMed Google Scholar
• Boland, M. V. & Murphy, R. F. Automated analysis of patterns in fluorescence-microscope images. Trends Cell Biol. 9, 201–202 (1999).
  CAS PubMed Google Scholar
• Boland, M. V. & Murphy, R. F. A neural network classifier capable of recognizing the patterns of all major subcellular structures in fluorescence microscope images of HeLa cells. Bioinformatics 17, 1213–1223 (2001).
  CAS PubMed Google Scholar
• Roques, E. J. S. & Murphy, R. F. Objective evaluation of differences in protein subcellular distribution. Traffic 3, 61–65 (2002).
  PubMed Google Scholar
• Hodges, M., Tissot, C., Howe, K., Grimwade, D. & Freemont, P. S. Structure, organization, and dynamics of promyelocytic leukemia protein nuclear bodies. Am. J. Hum. Genet. 63, 297–304 (1998).
  CAS PubMed PubMed Central Google Scholar
• Lelievre, S. A. et al. Tissue phenotype depends on reciprocal interactions between the extracellular matrix and the structural organization of the nucleus. Proc. Natl Acad. Sci. USA 95, 14711–14716 (1998).
  CAS PubMed PubMed Central Google Scholar
• Petersen, O. W., Ronnov-Jessen, L., Howlett, A. R. & Bissell, M. J. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc. Natl Acad. Sci. USA 89, 9064–9068 (1992).
  CAS PubMed PubMed Central Google Scholar
• Debnath, J. et al. The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. Cell 111, 29–40 (2002).
  CAS PubMed Google Scholar
• Debnath, J., Muthuswamy, S. K. & Brugge, J. S. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30, 256–268 (2003).
  CAS PubMed Google Scholar
• Weaver, V. M. et al. β4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. Cancer Cell 2, 205–216 (2002).
  CAS PubMed PubMed Central Google Scholar
• Shariat, S. F. et al. Risk stratification for bladder tumor recurrence, stage and grade by urinary nuclear matrix protein 22 and cytology. Eur. Urol. 45, 304–313 (2004).
  PubMed Google Scholar
• Partin, A. W. et al. Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer. Cancer Res. 53, 744–746 (1993).
  CAS PubMed Google Scholar
• Subong, E. N. et al. Monoclonal antibody to prostate cancer nuclear matrix protein (PRO:4-216) recognizes nucleophosmin/B23. Prostate 39, 298–304 (1999).
  CAS PubMed Google Scholar
• Keesee, S. K. et al. Preclinical feasibility study of NMP179, a nuclear matrix protein marker for cervical dysplasia. Acta Cytol. 43, 1015–1022 (1999).
  CAS PubMed Google Scholar